Astrazeneca’s lung cancer drug Imfinzi has been approved for treatment in the US to be used both before and after surgery, just days after the company’s market value hit £200bn for the first ...

Dave Fredrickson, highlighted in a company statement. ESMO: AstraZeneca's Imfinzi extends life in bladder cancer type. Will FDA push back on its perioperative trial design? The FDA based its ...

AstraZeneca's David Fredrickson is encouraged by the latest cancer research and discusses the four Ps: Policy, Politics, Priorities, and Prevention.

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab ... receiving the regimen were alive at two years compared to 75.2% in the comparator arm. Dave Fredrickson, executive vice president, ...